Clinical Trials Logo

Filter by:
NCT ID: NCT02948114 Terminated - Metabolomics Clinical Trials

The Effect of Feeding Infant Formula Containing Prebiotics and/or Probiotics

Start date: October 2016
Phase: N/A
Study type: Interventional

The study is intended to evaluate the microorganisms found in infant stools when consuming study formulas containing prebiotics and/or probiotics compared to infants consuming mother's own breast milk.

NCT ID: NCT02940548 Terminated - Hypertension Clinical Trials

Nifedipine GITS and Amlodipine Besylate on Recovery of Blood Pressure Rhythm and Arterial Stiffness

NARRAS
Start date: December 2016
Phase: Phase 4
Study type: Interventional

This trial evaluates the effects of Nifedipine GITS and Amlodipine besylate on blood pressure rhythm restoration and arterial stiffness in young and middle-aged non-dipper hypertensives. Half of participants will receive Nifedipine GITS, half of half will take medicine in the morning or at night. While the other half participants will take amlodipine besylate, whom will also be assigned taking medicine in the morning or at night. Ambulatory blood pressure monitoring and arterial stiffness examination will be performed before and after pharmaceutical intervention.

NCT ID: NCT02932345 Terminated - Clinical trials for EGFR Mutation Positive Advanced Non-small-cell Lung Cancer

Gefitinib Long-term Survivor Study

Start date: October 31, 2016
Phase:
Study type: Observational

The primary objective is to describe the genomic profile of long-term survivors, especially to find out potential genomic prognosis and/or predictive factors for gefitinib long-term efficacy as compared to rapid PD patients

NCT ID: NCT02920437 Terminated - Hypertension Clinical Trials

A Pilot Randomized Controlled Trial to Reduce Salt Intake Among Hypertensive Young Adults in Hong Kong

Start date: October 2016
Phase: N/A
Study type: Interventional

A pilot randomized controlled trial will be conducted to investigate the feasibility and effectiveness of a salt intake reduction intervention to young hypertension patients in Hong Kong who had high salt intake.

NCT ID: NCT02914015 Terminated - Analgesia Clinical Trials

Continous Quadratus Lumborum Block for Hepatic Surgery With Right Subcostal Incision

Start date: August 1, 2018
Phase: N/A
Study type: Interventional

This prospective, randomized study, control study aims to compare the analgesic effect, opioids consumption, quality of recovery, length of hospital stay and et al. between unilateral continuous quadratus lumborum block (QLB) and intravenous patient-controlled analgesia (IPCA) alone in patients undergoing hepatectomy with right J-shape subcostal incision.

NCT ID: NCT02895529 Terminated - Clinical trials for Hematologic Neoplasms

A Study Comparing the Efficacy of Intravenous Followed by Oral Itraconazole With Intravenous Caspofungin For Empiric Antifungal Therapy in Neutropenic Participants With Hematological Malignancy

Start date: November 30, 2016
Phase: Phase 4
Study type: Interventional

The purpose of this study is to investigate the hypothesis that the efficacy of intravenous (IV) itraconazole followed by oral itraconazole is non-inferior to that of intravenous caspofungin as empiric therapy for suspected fungal infection participants with fever and neutropenia.

NCT ID: NCT02893332 Terminated - Clinical trials for Stage IV EGFR Mutated Non-Small Cell Lung Cancer

Stereotactic Body Radiation Therapy (SBRT) in Newly Diagnosed Advanced Staged Lung Adenocarcinoma (Sindas)

Sindas
Start date: January 15, 2016
Phase: Phase 3
Study type: Interventional

To tested if the adding of consolidative SBRT to TKI in EGFR mutated patients with less than or equal to 5 metastatic sites (primary + 5) will improve progression free survival (PFS) compared to TKI alone.

NCT ID: NCT02882087 Terminated - Clinical trials for Moderate and Severe Rheumatoid Arthritis

A Study of the Efficacy and Safety of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Inadequate Response to TNF-α Antagonists Due to Treat Moderate and Severe Rheumatoid Arthritis

Start date: October 2015
Phase: Phase 2
Study type: Interventional

This is a phase Ⅱ, placebo-controlled, multicenter, dynamic randomized, double blind study of the efficacy and safety of RC18, a recombinant human B lymphocyte stimulating factor receptor-antibody fusion protein in subjects with inadequate response of TNF-α antagonists due to treat moderate and severe rheumatoid arthritis.

NCT ID: NCT02874651 Terminated - Clinical trials for Nasopharyngeal Neoplasms

ADjuVant Apatinib in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy

ADVANCE
Start date: October 2016
Phase: Phase 2
Study type: Interventional

This study will enroll patients with non-metastatic nasopharyngeal carcinoma (NPC) that have residual Epstein-Barr virus (EBV) DNA after curative radiotherapy or chemoradiotherapy. The purpose is to evaluate the survival in these patients treated with apatinib (YN968D1), an inhibitor of vascular endothelial growth factor receptor (phase IIa) and to compare the survival in these patients treated with apatinib versus placebo (phase IIb).

NCT ID: NCT02873702 Terminated - Erosive Esophagitis Clinical Trials

Efficacy and Safety of Dexlansoprazole in Healing and Maintaining Healing of Erosive Esophagitis

Start date: December 21, 2016
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine the efficacy of dexlansoprazole compared to lansoprazole in healing erosive esophagitis (EE) in Chinese participants.